Conference
Siena (Italy) & Online
June 27th – 28th, 2022
Tackling ethical, economical, legal, and social aspects of Personalised Medicine Conference
In 2014, the Horizon 2020 Advisory Group has defined PM as a medical model using characterization of individuals’ phenotypes and genotypes (e.g., molecular profiling, medical imaging and lifestyle data) to tailor the right therapeutic strategy to the right person at the right time, determine the predisposition to disease and deliver timely and targeted prevention. The definition has been adopted by the European Council Conclusion on PM for patients, which specified that “Personalised medicine relates to the broader concept of patient-centered care, which takes into account that, in general, healthcare systems need to better respond to patient needs” (2015/C 421/03).
While more and more countries are introducing whole genome sequencing and Personalised Medicine approaches into clinical care (i.e., the United Kingdom’s National Health Service plan to sequence 5 million genomes in 5 years and France and Canada which, at various stages, are kicking off publicly funded genomic healthcare services), the awareness about the ethical, economic, legal and social implication of Personalised Medicine are becoming central in the public discourse.
The focus of this Conference will, therefore, be on the following topics:
- Ethical aspects
- Public trust
- The economic value of Personalised Medicine
- Diversity, inclusion and Personalised Medicine
- Sex, gender and Personalised Medicine
LIVE STREAMING: https://www.youtube.com/watch?v=2EMCboSXSIE
Programme
Day 1, June 27th
12.30
In-person registration
&
Lunch
13.15
Online registration
13.30
Host greetings from the Toscana Life Sciences Foundation
Fabrizio Landi – President of the Board of Directors, Fondazione Toscana Life Sciences, Siena (Italy)
13.45
Host greetings from the European Commission
Jean-Luc Sanne – DG RTD Personalised Medicine, European Commission, Brussels (Belgium)
13.50
Introduction Regions4PerMed: the project, aim of the conference
Gianni D’Errico – R4PM Coordinator, Toscana Life Sciences Foundation, Firenze (Italy)
SESSION I
Ethical Aspects
13.55
Prof. Eva Winkler – National Center for Tumor Diseases, Heidelberg (Germany)
14.10
Prof. Giovanni Comandè – Professor, Scuola Superiore Sant’Anna di Pisa, Pisa (Italy)
14.25
Q&A
Discussion
SESSION II
Public Trust
14.40
Dr. David Wyatt – King’s College London, London (United Kingdom)
14.55
Prof. Alessandra Gorini – Professor, Department of Clinical Sciences and Community Health, Università degli Studi di Milano, Milano (Italy)
15.10
Q&A
Discussion
15.30
Coffee Break
SESSION III
The Economic Value of Personalised Medicine
15.50
Prof. Elio Borgonovi – Professor, School of Management – Bocconi University, Milan (Italy)
16.05
Dr. Rositsa Koleva-Kolarova – Senior Researcher, Health Economics Research Centre | HECO PerMed Project, Oxford (United Kingdom)
16.20
Q&A
Discussion
SESSION IV
Diversity, Inclusion and Personalised Medicine
16.40
Prof. Yvonne Bombard – Professor, Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto (Canada)
16.55
Dr. Maxine Mackintosh – Programme Lead, Diverse Data Initiative, Genomics England, London (United Kingdom)
17.10
Q&A
Discussion
SESSION V
Sex, Gender and Personalised Medicine
17.30
Dr. Susanna Chiocca – Department of Experimental Oncology, European Institute of Oncology IRCCS (IEO), Milan (Italy)
17.45
Prof. Victoria Tkachenko – The Shupyk National Healthcare University of Ukraine, Kyiv (Ukraine)
18.00
Q&A
Discussion
18.20
Wrap-up
Closure
Day 2, June 28th
08.45
Registration
IN SITU VISITS
(In person participation)
09.00
Toscana Life Sciences Foundation – History and main results achieved in the Life Sciences in Tuscany
Dr. Cristina Tinti – Incubation Manager, Fondazione Toscana Life Sciences, Siena (Italy)
09.30
Monoclonal Antibody Discovery Lab
Dr. Claudia Sala – Head of Monoclonal Antibody Discovery (MAD) Lab, Fondazione Toscana Life Sciences, Siena (Italy)
10.00
Regional Center for Personalised Medicine
Prof. Francesco Dotta –Professor, University of Siena, Siena (Italy)
10.30
Biomedical and Health Informatics Lab
Prof. Paolo Milazzo – Professor, Università di Pisa, Pisa (Italy)
11.00
Laboratory of Genomics and Epigenomics (LAGE)
Dr. Danilo Licastro – AREA Science Park, Trieste (Italy)
11.30
Coffee Break
12.00
IN-SITU VISIT LABS MRC
Closed Event for Region4PerMed Project Partners
13.00
Lunch
14.00
Consortium Meeting
Closed Event for Region4PerMed Project Partners
16.00
Closure
